Tumor necrosis factor inhibitor therapy for hepatitis B virus–infected individuals: How loud is the alarm bell?

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|62|1|16-18

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.62, Iss.1, 2015-07, pp. : 16-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

G1862T Mutation among Hepatitis B Virus-Infected Individuals: Association with Viral Genotypes and Disease Outcome in Kolkata, Eastern India

By  

Intervirology, Vol. 50, Iss. 3, 2007-01 ,pp. : 173-180

Karger

Access to resources Recommend Favorite

Antiviral Resistance Mutations and Genotype-Associated Amino Acid Substitutions in Treatment-Naïve Hepatitis B Virus-Infected Individuals from the Indian Subcontinent

By  

Intervirology, Vol. 55, Iss. 1, 2011-02 ,pp. : 36-44

Karger

Access to resources Recommend Favorite

Evaluation of Tumor Necrosis Factor inhibitor therapy in Susac syndrome

By  

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Significance of Hepatitis B Surface Antigen in Cord Blood of Hepatitis B e-Antigen-Negative Chronic Hepatitis B Virus-Infected Mothers

By  

Intervirology, Vol. 52, Iss. 3, 2009-05 ,pp. : 132-134

Karger

Access to resources Recommend Favorite

Mycobacterial cervicofacial lymphadenitis in human immunodeficiency virus–infected individuals after antiretroviral therapy initiation

By  

THE LARYNGOSCOPE, Vol. 125, Iss. 11, 2015-11 ,pp. : 2498-2502

John Wiley & Sons Inc

Access to resources Recommend Favorite